Search

Eric D Turtle

from Belmont, CA
Age ~53
Get Report
Also known as:
Eric Y Fang, Vivian Li
Phone and address:
2703 Monserat Ave, Belmont, CA 94002
(650) 592-6368
Related to:
Man ChenTammy M Lee, 53Zi H LiChin L Fan, 84Kai L Ung, 96
Connected to:
Julie L Turtle, 68Nina L Turtle, 66Lorraine S Turton, 56Margaret E Turton, 55Paula M Turton, 42Robin M Turton, 57Blanca R Turturiello, 82Charlotte TurturilloChristopher A Turtzo, 44Craig H Turtzo, 75

Eric Turtle Phones & Addresses

  • 2703 Monserat Ave, Belmont, CA 94002 (650) 592-6368
  • Bridgewater, NJ
  • Hayward, CA
  • Foster City, CA
  • Emeryville, CA
  • Berkeley, CA
  • Orlando, FL
  • Piscataway, NJ
  • Marlton, NJ
  • 2703 Monserat Ave, Belmont, CA 94002

Work

Company: Novabay pharmaceuticals - Emeryville, CA Nov 2009 Position: Senior scientist

Education

School / High School: University of California- Berkeley, CA 1993 Specialities: Ph. D. in Organic Chemistry

Skills

Organic synthesis • medicinal chemistry

Industries

Pharmaceuticals

Resumes

Resumes

Eric Turtle Photo 1

Eric Turtle

View page
Location:
San Francisco Bay Area
Industry:
Pharmaceuticals
Eric Turtle Photo 2

Eric Turtle Belmont, CA

View page
Work:
NovaBay Pharmaceuticals
Emeryville, CA
Nov 2009 to Apr 2011
Senior Scientist
FibroGen Inc
San Francisco, CA
Jun 2001 to Jul 2009
Principal Scientist
Praecis Pharmaceuticals Inc
Piscataway, NJ
Dec 1998 to Apr 2001
Research Scientist I, Research Scientist II
University of California
Berkeley, CA
1993 to 1998
Graduate Research Assistant
Education:
University of California
Berkeley, CA
1993 to 1998
Ph. D. in Organic Chemistry
Harvey Mudd College
Claremont, CA
1989 to 1993
B.S. in Chemistry
Skills:
Organic synthesis, medicinal chemistry

Business Records

Name / Title
Company / Classification
Phones & Addresses
Eric Turtle
Research Scientist
FibroGen, Inc.
Biotechnology · Mfg Pharmaceutical Preparations · Physical Medicine
409 Illinois St, San Francisco, CA 94158
(415) 978-1200, (415) 978-1902, (800) 720-7203

Publications

Us Patents

Nitrogen-Containing Heteroaryl Compounds And Methods Of User Thereof

View page
US Patent:
7629357, Dec 8, 2009
Filed:
May 26, 2006
Appl. No.:
11/442727
Inventors:
Michael P. Arend - Forster City CA, US
Lee A. Flippin - Woodside CA, US
Eric Turtle - Belmont CA, US
Xiaohui Du - Foster City CA, US
Assignee:
FibroGen, Inc. - San Francisco CA
International Classification:
C07D 217/02
A61K 31/47
US Classification:
514309, 546141, 546146, 514307
Abstract:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Pyrrolo- And Thiazolo-Pyridine Compounds, And Methods Of Use Thereof

View page
US Patent:
7696223, Apr 13, 2010
Filed:
Apr 4, 2007
Appl. No.:
11/696549
Inventors:
Shaojiang Deng - San Mateo CA, US
Min Wu - Sunnyvale CA, US
Eric D. Turtle - Belmont CA, US
Wen-Bin Ho - Los Altos CA, US
Michael P. Arend - Foster City CA, US
Heng Cheng - Foster City CA, US
Lee A. Flippin - Woodside CA, US
Assignee:
FibroGen, Inc. - San Francisco CA
International Classification:
A61K 31/435
C07D 471/02
US Classification:
514301, 546113, 546114
Abstract:
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).

Nitrogen-Containing Heteroaryl Compounds And Methods Of Use Thereof

View page
US Patent:
7863292, Jan 4, 2011
Filed:
Jan 19, 2007
Appl. No.:
11/624949
Inventors:
Michael P. Arend - Foster City CA, US
Lee A. Flippin - Woodside CA, US
Wen-Bin Ho - Los Altos CA, US
Eric Turtle - Belmont CA, US
Xiaohui Du - Foster City CA, US
Assignee:
FibroGen, Inc. - San Francisco CA
International Classification:
C07D 403/02
A61K 31/47
US Classification:
514310, 546146
Abstract:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Cyanoisoquinoline Compounds And Methods Of Use Thereof

View page
US Patent:
7928120, Apr 19, 2011
Filed:
Jan 26, 2007
Appl. No.:
11/627906
Inventors:
Michael Arend - Foster City CA, US
Lee A. Flippin - Woodside CA, US
Min Wu - Sunnyvale CA, US
Eric D. Turtle - Belmont CA, US
Wen-Bin Ho - Los Altos CA, US
Shaojiang Deng - San Mateo CA, US
Assignee:
FibroGen, Inc. - San Francisco CA
International Classification:
A01N 43/42
A01N 43/40
A61K 31/47
A61K 31/435
A61K 31/44
US Classification:
514307, 514277, 514279, 514299
Abstract:
The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:.

Nitrogen-Containing Heteroaryl Compounds And Methods Of Use Thereof

View page
US Patent:
8017625, Sep 13, 2011
Filed:
Jan 16, 2008
Appl. No.:
12/015275
Inventors:
Michael P. Arend - San Mateo CA, US
Lee A. Flippin - Woodside CA, US
Eric Turtle - Belmont CA, US
Xiaohui Du - Foster City CA, US
Assignee:
Fibrogen, Inc. - South San Francisco CA
International Classification:
C07D 217/12
A61K 31/47
US Classification:
514309, 546146
Abstract:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Oxazolopyridine And Isoxazolopyridine Derivatives For Use In The Treatment Of Hif-Mediated Conditions

View page
US Patent:
8269008, Sep 18, 2012
Filed:
Dec 2, 2008
Appl. No.:
12/734895
Inventors:
Michael P. Arend - Foster City CA, US
Heng Cheng - Foster City CA, US
Lee A. Flippin - Woodside CA, US
Danny Ng - Daly City CA, US
Eric D. Turtle - Belmont CA, US
Min Wu - Sunnyvale CA, US
Assignee:
FibroGen, Inc. - San Francisco CA
International Classification:
C07D 221/18
C07D 221/02
C07D 221/22
A01N 43/42
A01N 43/40
A61K 31/44
A61K 31/435
A61P 25/00
A61P 3/04
C07C 63/00
C07C 65/00
C12N 9/99
C12N 9/14
US Classification:
546116, 546 26, 546112, 546115, 424 946, 424 9463, 435183, 435154, 435195, 435212, 514 135, 514 164, 514 175, 514 177, 514277, 514299, 514302, 514338, 514339, 514344, 514345, 514346, 514350, 514351, 562400, 562405, 562433, 562443
Abstract:
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.

Nitrogen-Containing Heteroaryl Compounds And Methods Of Use Thereof

View page
US Patent:
8278325, Oct 2, 2012
Filed:
Jul 19, 2011
Appl. No.:
13/186351
Inventors:
Michael P. Arend - San Mateo CA, US
Lee A. Flippin - Woodside CA, US
Wen-Bin Ho - Los Altos CA, US
Eric Turtle - Belmont CA, US
Xiaohui Du - Foster City CA, US
Assignee:
FibroGen, Inc. - San Francisco CA
International Classification:
C07D 217/26
A61K 31/472
US Classification:
514309, 546141
Abstract:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Chromene Derivatives And Use Thereof As Hif Hydroxylase Activity Inhibitors

View page
US Patent:
8324405, Dec 4, 2012
Filed:
Feb 5, 2009
Appl. No.:
12/866023
Inventors:
Wen-bin Ho - San Francisco CA, US
Lee Wright - San Francisco CA, US
Shaojiang Deng - San Francisco CA, US
Eric Turtle - San Francisco CA, US
Lee A. Flippin - San Francisco CA, US
Assignee:
FibroGen, Inc. - San Francisco CA
International Classification:
C07D 311/02
US Classification:
549285
Abstract:
The present invention relates to novel compounds of formula (I), methods, and compositions capable of decreasing HIF hydroxylase activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF).
Control profile
Eric D Turtle from Belmont, CA, age ~53 Get Report